jueves, 19 de septiembre de 2019

Sandoz halts global distribution of heartburn med over carcinogen link

Sandoz halts global distribution of heartburn med over carcinogen link

The Readout

Damian Garde

More reads

  • Sandoz halts global distribution of heartburn med over carcinogen link while Canada tells other manufacturers to stop. (STAT Plus)
  • Medicxi founds biotech to Divide & Conquer tough solid tumors. (FierceBiotech)
  • Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns. (STAT Plus)

No hay comentarios: